S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions

TScan Therapeutics (TCRX) Earnings Date, Estimates & Call Transcripts

$6.56
-0.14 (-2.09%)
(As of 12/8/2023 ET)
Compare
Today's Range
$6.56
▼
$6.90
50-Day Range
$2.66
▼
$6.76
52-Week Range
$1.45
▼
$7.15
Volume
64,591 shs
Average Volume
128,729 shs
Market Capitalization
$313.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.50
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Mar. 13Estimated
Actual EPS
(Nov. 9)
-$0.24 Beat By $0.19
Consensus EPS
(Nov. 9)
-$0.43
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

TCRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TCRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

TScan Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20232($0.80)($0.70)($0.75)
Q2 20233($1.04)($0.27)($0.77)
Q3 20233($1.00)($0.25)($0.58)
Q4 20234($1.00)$0.12($0.35)
FY 202312($3.84)($1.10)($2.45)
Q1 20241($0.26)($0.26)($0.26)
Q2 20241($0.26)($0.26)($0.26)
Q3 20241($0.26)($0.26)($0.26)
Q4 20241($0.24)($0.24)($0.24)
FY 20244($1.02)($1.02)($1.02)

TCRX Earnings Date and Information

TScan Therapeutics last announced its earnings data on November 9th, 2023. The reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.43) by $0.19. The business earned $3.89 million during the quarter, compared to analyst estimates of $3.80 million. TScan Therapeutics has generated ($2.46) earnings per share over the last year (($2.46) diluted earnings per share). Earnings for TScan Therapeutics are expected to grow in the coming year, from ($1.43) to ($1.22) per share. TScan Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 13th, 2024 based off prior year's report dates.

TScan Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/13/2024
Estimated)		------- 
11/9/2023Q3 2023($0.43)($0.24)+$0.19($0.24)$3.80 million$3.89 million
8/10/2023Q2 2023($0.76)($0.51)+$0.25($0.51)$3.75 million$3.15 million
5/10/2023Q1 2023($0.73)($0.93)($0.20)($0.93)$3.10 million$6.80 million
3/8/2023Q4 2022($0.73)($0.78)($0.05)($0.78)$2.63 million$3.10 million
11/9/2022Q3 2022($0.73)($0.67)+$0.06($0.67)$3.73 million$3.36 million
8/10/2022Q2 2022($0.76)($0.63)+$0.13($0.63)$2.66 million$4.06 million
5/9/2022Q1 2022($0.69)($0.67)+$0.02($0.67)$2.21 million$3.02 million
11/10/2021Q3 2021($0.61)($0.80)($0.19)($0.80)-$2.41 million
8/18/2021Q2 2021($0.65)($7.69)($7.04)($7.69)-$2.85 million












TScan Therapeutics Earnings - Frequently Asked Questions

When is TScan Therapeutics's earnings date?

TScan Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 13th, 2024 based off last year's report dates. Learn more on TCRX's earnings history.

Did TScan Therapeutics beat their earnings estimates last quarter?

In the previous quarter, TScan Therapeutics (NASDAQ:TCRX) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.43) by $0.19. Learn more on analysts' earnings estimate vs. TCRX's actual earnings.

How much revenue does TScan Therapeutics generate each year?

TScan Therapeutics (NASDAQ:TCRX) has a recorded annual revenue of $13.53 million.

How much profit does TScan Therapeutics generate each year?

TScan Therapeutics (NASDAQ:TCRX) has a recorded net income of -$66.22 million. TCRX has generated -$2.46 earnings per share over the last four quarters.

What is TScan Therapeutics's EPS forecast for next year?

TScan Therapeutics's earnings are expected to grow from ($1.43) per share to ($1.22) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:TCRX) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -